• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管通透性和纹理参数对评估食管鳞状细胞癌患者新辅助放化疗反应的诊断性能

Diagnostic Performance of Vascular Permeability and Texture Parameters for Evaluating the Response to Neoadjuvant Chemoradiotherapy in Patients With Esophageal Squamous Cell Carcinoma.

作者信息

Ji Wenbing, Wang Jian, Zhou Rongzhen, Wang Minke, Wang Weizhen, Pang Peipei, Kong Min, Zhou Chao

机构信息

Department of Radiology, Taizhou Hospital of Zhejiang Province, Taizhou, China.

Advanced Application Team, GE Healthcare, Shanghai, China.

出版信息

Front Oncol. 2021 May 18;11:604480. doi: 10.3389/fonc.2021.604480. eCollection 2021.

DOI:10.3389/fonc.2021.604480
PMID:34084740
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8168434/
Abstract

BACKGROUND

Esophageal squamous cell carcinoma (ESCC) is an aggressive type of cancer, associated with poor prognosis. The development of an accurate and non-invasive method to evaluate the pathologic response of patients with ESCC to chemoradiotherapy remains a critical issue. Therefore, the aim of this study was to assess the importance of vascular permeability and texture parameters in predicting the response to neoadjuvant chemoradiotherapy (NACRT) in patients with ESCC.

METHODS

This prospective analysis included patients with T1-T2 stage of ESCC, without either lymphatic or metastasis, and distant metastasis. All patients underwent surgery having received two rounds of NACRT. All patients underwent dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) twice, i.e., before the first NACRT and after the second NACRT. Patients were assessed for treatment response at 30 days after the second NACRT. Patients were divided into the complete response (CR) and partial response (PR) groups based on their responses to NACRT. Vascular permeability and texture parameters were extracted from the DCE-MRI scans. After assessing the diagnostic performance of individual parameters, a combined model with vascular permeability and texture parameters was generated to predict the response to NACRT.

RESULTS

In this study, the CR and PR groups included 16 patients each. The volume transfer constant (Ktrans), extracellular extravascular volume fraction (ve), and entropy values, as well as changes to each of these parameters, extracted from the second DCE-MRI scans, showed significant differences between the CR and PR groups. The area under the curve (AUC) of Ktrans, ve, and entropy values showed good diagnostic ability (0.813, 0.789, and 0.707, respectively). A logistic regression model combining Ktrans, ve, and entropy had significant diagnostic ability (AUC=0.977).

CONCLUSIONS

The use of a combined model with vascular permeability and texture parameters can improve post-NACRT prognostication in patients with ESCC.

摘要

背景

食管鳞状细胞癌(ESCC)是一种侵袭性癌症,预后较差。开发一种准确且非侵入性的方法来评估ESCC患者对放化疗的病理反应仍然是一个关键问题。因此,本研究的目的是评估血管通透性和纹理参数在预测ESCC患者对新辅助放化疗(NACRT)反应中的重要性。

方法

这项前瞻性分析纳入了T1 - T2期的ESCC患者,这些患者无淋巴转移和远处转移。所有患者在接受两轮NACRT后接受手术。所有患者在第一次NACRT前和第二次NACRT后各进行了两次动态对比增强磁共振成像(DCE - MRI)检查。在第二次NACRT后30天评估患者的治疗反应。根据患者对NACRT的反应将其分为完全缓解(CR)组和部分缓解(PR)组。从DCE - MRI扫描中提取血管通透性和纹理参数。在评估各个参数的诊断性能后,生成了一个包含血管通透性和纹理参数的联合模型来预测对NACRT的反应。

结果

在本研究中,CR组和PR组各有16例患者。从第二次DCE - MRI扫描中提取的容积转移常数(Ktrans)、细胞外血管外容积分数(ve)和熵值,以及这些参数各自的变化,在CR组和PR组之间显示出显著差异。Ktrans、ve和熵值的曲线下面积(AUC)显示出良好的诊断能力(分别为0.813、0.789和0.

相似文献

1
Diagnostic Performance of Vascular Permeability and Texture Parameters for Evaluating the Response to Neoadjuvant Chemoradiotherapy in Patients With Esophageal Squamous Cell Carcinoma.血管通透性和纹理参数对评估食管鳞状细胞癌患者新辅助放化疗反应的诊断性能
Front Oncol. 2021 May 18;11:604480. doi: 10.3389/fonc.2021.604480. eCollection 2021.
2
Does the computed tomography perfusion imaging improve the diagnostic accuracy in the response evaluation of esophageal carcinoma to the neoadjuvant chemoradiotherapy? Preliminary study.计算机断层扫描灌注成像能否提高食管癌新辅助放化疗反应评估的诊断准确性?初步研究。
J BUON. 2014 Jan-Mar;19(1):237-44.
3
Dynamic contrast-enhanced MRI for advanced esophageal cancer response assessment after concurrent chemoradiotherapy.动态对比增强磁共振成像用于同步放化疗后晚期食管癌反应评估
Diagn Interv Radiol. 2018 Jul;24(4):195-202. doi: 10.5152/dir.2018.17369.
4
[Application value of texture analysis of magnetic resonance images in prediction of neoadjuvant chemoradiotherapy efficacy for rectal cancer].磁共振图像纹理分析在预测直肠癌新辅助放化疗疗效中的应用价值
Zhonghua Wei Chang Wai Ke Za Zhi. 2018 Sep 25;21(9):1051-1058.
5
Diagnostic performance of dynamic contrast-enhanced magnetic resonance imaging parameters and serum tumor markers in rectal carcinoma prognosis.动态对比增强磁共振成像参数和血清肿瘤标志物在直肠癌预后中的诊断效能
World J Gastrointest Oncol. 2024 May 15;16(5):1796-1807. doi: 10.4251/wjgo.v16.i5.1796.
6
Assessment of esophageal carcinoma undergoing concurrent chemoradiotherapy with quantitative dynamic contrast-enhanced magnetic resonance imaging.采用定量动态对比增强磁共振成像评估同步放化疗的食管癌
Oncol Lett. 2015 Dec;10(6):3607-3612. doi: 10.3892/ol.2015.3779. Epub 2015 Oct 5.
7
Neoadjuvant Chemotherapy or Neoadjuvant Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: Real-World Data Comparison from A Japanese Nationwide Study.新辅助化疗或新辅助放化疗治疗食管鳞癌患者:来自日本全国性研究的真实世界数据比较。
Ann Surg Oncol. 2023 Sep;30(9):5885-5894. doi: 10.1245/s10434-023-13686-y. Epub 2023 Jun 1.
8
SUV reduction predicts long-term survival in patients of non-pCR both in the tumor and lymph nodes after neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma.SUV 降低预示着新辅助放化疗后食管鳞癌患者肿瘤和淋巴结非完全病理缓解(non-pCR)时的长期生存。
World J Surg Oncol. 2021 Apr 9;19(1):105. doi: 10.1186/s12957-021-02208-3.
9
Current status of and perspectives regarding neoadjuvant chemoradiotherapy for locally advanced esophageal squamous cell carcinoma.局部晚期食管鳞状细胞癌新辅助放化疗的现状与展望
Surg Today. 2016 Mar;46(3):261-7. doi: 10.1007/s00595-015-1144-0. Epub 2015 Mar 5.
10
Histogram analysis of DCE-MRI for chemoradiotherapy response evaluation in locally advanced esophageal squamous cell carcinoma.DCE-MRI 直方图分析在局部晚期食管鳞癌放化疗疗效评估中的应用。
Radiol Med. 2020 Feb;125(2):165-176. doi: 10.1007/s11547-019-01081-1. Epub 2019 Oct 11.

引用本文的文献

1
Association of dynamic contrast-enhanced MRI and F-Fluorodeoxyglucose PET/CT parameters with neoadjuvant therapy response and survival in esophagogastric cancer.动态对比增强 MRI 和 F-氟脱氧葡萄糖 PET/CT 参数与食管胃交界癌新辅助治疗反应和生存的相关性。
Eur J Surg Oncol. 2023 Oct;49(10):106934. doi: 10.1016/j.ejso.2023.05.009. Epub 2023 May 10.

本文引用的文献

1
Preliminary study on identification of estrogen receptor-positive breast cancer subtypes based on dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) texture analysis.基于动态对比增强磁共振成像(DCE-MRI)纹理分析的雌激素受体阳性乳腺癌亚型识别初步研究
Gland Surg. 2020 Jun;9(3):622-628. doi: 10.21037/gs.2020.04.01.
2
Magnetic Resonance Imaging Radiomics Analyses for Prediction of High-Grade Histology and Necrosis in Clear Cell Renal Cell Carcinoma: Preliminary Experience.磁共振成像放射组学分析预测肾透明细胞癌高级别组织学和坏死:初步经验。
Clin Genitourin Cancer. 2021 Feb;19(1):12-21.e1. doi: 10.1016/j.clgc.2020.05.011. Epub 2020 May 23.
3
[Epidemiological characteristic and current status of surgical treatment for esophageal cancer by analysis of national registry database].
通过国家登记数据库分析食管癌外科治疗的流行病学特征及现状
Zhonghua Zhong Liu Za Zhi. 2020 Mar 23;42(3):228-233. doi: 10.3760/cma.j.cn112152-20191112-00729.
4
Prognostic Value of Texture Analysis Based on Pretreatment DWI-Weighted MRI for Esophageal Squamous Cell Carcinoma Patients Treated With Concurrent Chemo-Radiotherapy.基于治疗前弥散加权磁共振成像的纹理分析对同步放化疗的食管鳞状细胞癌患者的预后价值
Front Oncol. 2019 Oct 17;9:1057. doi: 10.3389/fonc.2019.01057. eCollection 2019.
5
The value of GRASP on DCE-MRI for assessing response to neoadjuvant chemotherapy in patients with esophageal cancer.GRASP 在评估食管癌新辅助化疗反应中的 DCE-MRI 价值。
BMC Cancer. 2019 Oct 24;19(1):999. doi: 10.1186/s12885-019-6247-3.
6
Textural features on 18F-FDG PET/CT and dynamic contrast-enhanced MR imaging for predicting treatment response and survival of patients with hypopharyngeal carcinoma.18F-FDG PET/CT及动态对比增强磁共振成像的纹理特征对下咽癌患者治疗反应及生存的预测作用
Medicine (Baltimore). 2019 Aug;98(33):e16608. doi: 10.1097/MD.0000000000016608.
7
Neoadjuvant treatment strategy for locally advanced thoracic esophageal cancer.局部晚期胸段食管癌的新辅助治疗策略
Ann Gastroenterol Surg. 2019 Mar 1;3(3):269-275. doi: 10.1002/ags3.12243. eCollection 2019 May.
8
Whole-tumour histogram analysis of pharmacokinetic parameters from dynamic contrast-enhanced MRI in resectable oesophageal squamous cell carcinoma can predict T-stage and regional lymph node metastasis.动态对比增强 MRI 药代动力学参数全肿瘤直方图分析可预测可切除食管鳞癌的 T 分期和区域淋巴结转移。
Eur J Radiol. 2019 Mar;112:112-120. doi: 10.1016/j.ejrad.2019.01.012. Epub 2019 Jan 14.
9
Monitoring of tumor vascular normalization: the key points from basic research to clinical application.肿瘤血管正常化监测:从基础研究到临床应用的要点
Cancer Manag Res. 2018 Oct 3;10:4163-4172. doi: 10.2147/CMAR.S174712. eCollection 2018.
10
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.